Drawing for A&Z

USPTO serial 75852134

A&Z

Reviewed by CopyMark Law Group

Reg. 2633870Status 800Registered
Filing date
Status date
Registration date
Oct 15, 2002
Examiner
JOHNSON, AISHA CLARKE
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with A&Z?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nancy A. Del Pizzo

Nancy A. Del Pizzo Rivkin Radler LLP25 Main StreetCourt Plaza North, Suite 501Hackensack, NJ 07601

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICALS, PREPARATIONS FOR THE TREATMENT OF ACNE, ANEMIA, ARTHRITIS, ASTHMA, BACTERIAL INFECTIONS, COLD and COUGH, CONSTIPATION, DANDRUFF, DIARRHEA, DISEASES OF THE CENTRAL NERVOUS SYSTEM, FEVER, FUNGAL INFECTIONS, HEMORRHOIDS, HERPES, HEARTBURN, INFLAMMATION, INTESTINAL GAS, MIGRAINES, NASAL AND SINUS CONGESTION, NAUSEA, POOR RESPIRATION, RESPIRATOR INFECTIONS, SORE THROAT, STOMACH ACHE, MOUTH PAIN CAUSED BY TEETHING; AND MUSCLE PAIN; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION OF ACNE, ANEMIA, ARTHRITIS, ASTHMA, BACTERIAL INFECTIONS, COLD and COUGH, CONSTIPATION, DANDRUFF, DIARRHEA, DISEASES OF THE CENTRAL NERVOUS SYSTEM, FEVER, FUNGAL INFECTIONS, HEMORRHOIDS, HERPES, HEARTBURN, INFLAMMATION, INTESTINAL GAS, MIGRAINES, NASAL AND SINUS CONGESTION, NAUSEA, POOR RESPIRATION, RESPIRATORY INFECTIONS, SORE THROAT, STOMACH ACHE, MOUTH PAIN CAUSED BY TEETHING, AND MUSCLE PAIN; AMINO ACIDS FOR USE AS NUTRITIONAL SUPPLEMENTS; ANESTHETIC FOR SURGICAL PURPOSES; TOPICAL ANESTHETICS; ANESTHETICS FOR NON-SURGICAL USE; ANTIBIOTICS; ANTIBIOTIC CREAMS; ANTIBIOTIC OINTMENTS; ANTIBIOTIC TABLETS; ANTIHISTAMINES AND ANTIHISTAMINE COMBINATIONS IN THE NATURE OF COLD AND ALLERGY REMEDIES; * CALCIUM SUPPLEMENTS FOR THE TREATMENT OF OSTEOPOROSIS * CALCIUM SUPPLEMENTS FOR THE PREVENTION OF OSTEOPOROSIS; CARDIOVASCULAR PHARMACEUTICALS; CONTRACEPTIVE FORMS; CONTRACEPTIVE SPONGES; ORAL CONTRACEPTIVES; DENTAL NEEDS, NAMELY MEDICATED MOUTHWASH; DENTAL NEEDS, NAMELY DENTAL ABRASIVES; DENTAL NEEDS, NAMELY DENTAL AMALGAMS; DENTAL NEEDS, NAMELY DENTAL BLEACHING GELS, DENTAL NEEDS, NAMELY DENTAL IMPRESSION MATERIALS; DENTAL NEEDS, NAMELY MEDICATED TOOTH PASTE; ROOM DEODORANTS; DIAGNOSTIC REPARATIONS FOR CLINICAL OR MEDICAL LABORATORY USE; DIAPER RASH OINTMENT; DIET AIDS, NAMELY DIET CAPSULES AND DIET PILLS; ELECTROLYTE REPLACEMENT SOLUTIONS; ELECTROLYTE REPLACEMENT TABLETS; ENZYMES FOR USE AS A DIETARY SUPPLEMENT; EYE DROPS; EYE OINTMENTS; MEDICATED FOOT POWDER; MEDICATED HAIR GROWTH STIMULANTS; NON-MEDICATED HAIR GROWTH STIMULANTS; GEL FOR USE AS PERSONAL LUBRICANT; PREGNANCY TEST KITS FOR HOME USE; MEDICATED HAIR SHAMPOO; MEDICATED SKINCARE PREPARATIONS; SLEEP AIDS NAMELY SLEEPING PILLS AND TABLETS; VAGINAL PREPARATIONS, NAMELY ANTI- FUNGALS; MEDICATED NAILCARE AND NOSECARE PREPARATIONS; AND NUTRACEUTICAL, HERBAL AND DIETARY SUPPLEMENTSACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Oct 1, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 1, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 1, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 1, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 17, 2022NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Aug 17, 2022RNL2REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Aug 17, 202289AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Aug 16, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 2, 2022E89RTEAS SECTION 8 & 9 RECEIVED—
Dec 14, 2011RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Dec 14, 201189AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Dec 12, 2011E89RTEAS SECTION 8 & 9 RECEIVED—
Oct 17, 2008MDSMNOTICE OF DESIGN SEARCH CODE MAILED—
Apr 21, 2008C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 28, 2008FAXXFAX RECEIVED—
Jan 10, 2008PLGLASSIGNED TO PARALEGAL—
Jan 8, 2008E815TEAS SECTION 8 & 15 RECEIVED—
Oct 10, 2007CFITCASE FILE IN TICRS—
May 2, 2003COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Jan 14, 2003AMD7SEC 7 REQUEST FILED—
Jan 14, 2003MAILPAPER RECEIVED—
Oct 15, 2002R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 23, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 3, 2002NPUBNOTICE OF PUBLICATION—
Apr 4, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 28, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 12, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 2, 2001CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 29, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 26, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance